Tisolagiline (KDS2010) is a reversible MAO-B inhibitor used in Parkinson's disease research.
References:
[1]. Nam MH, et al. KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease. Neurotherapeutics. 2021 Jul;18(3):1729-1747.
















